Log in or Sign up for Free to view tailored content for your specialty!
Cornea/External Disease News
VIDEO: Apthera IOL demonstrates good early results in nondominant eyes
TAMPA, Fla. — In this Healio Video Perspective from the Telling It Like It Is meeting, Elizabeth Yeu, MD, discusses the positive results that the IC-8 Apthera IOL has shown for corneal astigmatism in nondominant eyes.
Q&A: Early diagnosis, treatment key in management of patients with neurotrophic keratitis
Healio spoke with Clark Chang, OD, MSA, MSc, FAAO, FSLS, director of specialty contact lenses at the Cornea Service of Wills Eye Hospital in Philadelphia, about the importance of early diagnosis of neurotrophic keratitis and considerations for treatment.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Upneeq helps clinician take more accurate fundus photos
ATLANTA — The use of Upneeq in patients with age-related ptosis has helped one clinician obtain more complete fundus images.
VIDEO: Clinician finds success with new Acuvue lens in computer users, older patients
ATLANTA — In this video, Luis Rojas, OD, a practitioner in McKinney, Texas, explains how he chooses contact lenses by combining a patient’s objective findings from the comprehensive exam with subjective findings or visual task requirements.
Bruder adds anti-inflammatory hydrating drink to its dry eye portfolio
Bruder Healthcare has announced an exclusive licensing agreement with Dry Eye Drink to sell the doctor-formulated, hyper-hydrating drink mixes for adults with dry eye disease.
2023 Island Eyes Conference: Visual hallucinations, maximizing blood tests and more
In this Healio video, Breanne B. McGhee, OD, FAAO, a featured speaker at the 2023 Island Eyes Conference in Hawaii, discusses key elements from three presentations she gave, as well as highlights from other educational sessions.
Reproxalap demonstrates safety in dry eye trial, with visual acuity improvement
Treatment-related serious adverse events in ocular safety, the primary endpoints in a 12-month safety clinical trial of reproxalap for the treatment of dry eye disease, were not observed, according to an Aldeyra Therapeutics press release.
BLOG: Corneal haze after pediatric cross-linking has no long-term effect
In adults, corneal haze following cross-linking is uncommon and resolves quickly.
Harrow launches next-generation compounded atropine formulations
Eye care pharmaceutical company Harrow announced the launch of its next-generation compounded atropine formulations, which are now available at ImprimisRx, its compounding and mail-order pharmacy subsidiary.
VIDEO: Preoperative treatment needed for corneal dystrophy
KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2023, Douglas A. Katsev, MD, discusses map-dot-fingerprint dystrophy.
-
Headline News
We must make our voices heard and vote in the 2024 election
September 18, 20247 min read -
Headline News
Semaglutide improves glucose control in automated insulin delivery for type 1 diabetes
September 20, 20243 min read -
Headline News
Oncologists, primary care clinicians should be aware of BRCA testing indications in men
September 19, 20244 min read
-
Headline News
We must make our voices heard and vote in the 2024 election
September 18, 20247 min read -
Headline News
Semaglutide improves glucose control in automated insulin delivery for type 1 diabetes
September 20, 20243 min read -
Headline News
Oncologists, primary care clinicians should be aware of BRCA testing indications in men
September 19, 20244 min read